Published :
Tables : 45
Figures : 42
Category : Healthcare
No. of Pages : 214
Report Code : HC-U9356
Human Rabies Vaccines Market Overview: Rabies is defined as a serious disease caused by the rabies virus. The rabies virus is a member of the Rhabodoviridae family and is generally found in animals. Humans are most likely to become infected by the bites of animals such as dogs, cats, bats, and other mammals. The rabies virus attacks the central nervous system, causing serious damage to the brain and, in extreme instances, death. Anxiety, paralysis, excessive salivation, hallucination, sleeplessness, hydrophobia, and other symptoms are common with rabies. As a result, rabies prophylaxis is critical, and vaccinations derived from inactivated rabies virus tend to greatly increase the worldwide human rabies vaccines market. Rabies is diagnosed in both animals and humans following the emergence of particular symptoms such as hydrophobia (fear of water) or aerophobia (fear of flying) (difficulty in respiration). These late-stage signs of infection can be lethal, hence an HRV should be delivered quickly after being bitten by rabid animals, even if these symptoms are not present. Human rabies vaccination can be given to people with the following forms of rabies: Patients with livid rabies exhibit hyperactivity, hydrophobia, and aerophobia, and die after a few days owing to cardiopulmonary collapse. The course of paralytic rabies is longer than that of livid rabies. The muscle at the location of the wound becomes paralysed. Then, gradually, unconsciousness sets in, eventually leading to death. This kind is frequently misdiagnosed. It accounts for 30 percent of all human cases. FutureWise Market Research has instantiated a report that provides an intricate analysis of Human Rabies Vaccines Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Human Rabies Vaccines Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Human Rabies Vaccines Market: • Serum Institute of India • Sanofi Pasteur,Inc • Novartis Vaccines and Diagnostics,Ltd • Cadila Pharmaceuticals Ltd • Merck and Co.Inc • Glaxosmithkline Biologicals • Berna Biotech Ltd • Wyeth pharmaceuticals • Medimmune LLC • Cipla,Inc (Note: The list of the major players will be updated with the latest market scenario and trends) Human Rabies Vaccines Market Segmentation: By Product Type • Vero Cell Rabies Vaccine • Baby Hamster Kidney (BHK) • Chick Embryo Cell Rabies Vaccine • Others By Application • Pre-Exposure Prophylaxis • Post-Exposure Prophylaxis By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Human Rabies Vaccines Market Sample Video: Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Human Rabies Vaccines Market By Product Type, By Application and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Rabies is defined as a serious disease caused by the rabies virus. The rabies virus is a member of the Rhabodoviridae family and is generally found in animals. Humans are most likely to become infected by the bites of animals such as dogs, cats, bats, and other mammals. The rabies virus attacks the central nervous system, causing serious damage to the brain and, in extreme instances, death. Anxiety, paralysis, excessive salivation, hallucination, sleeplessness, hydrophobia, and other symptoms are common with rabies. As a result, rabies prophylaxis is critical, and vaccinations derived from inactivated rabies virus tend to greatly increase the worldwide human rabies vaccines market. Rabies is diagnosed in both animals and humans following the emergence of particular symptoms such as hydrophobia (fear of water) or aerophobia (fear of flying) (difficulty in respiration). These late-stage signs of infection can be lethal, hence an HRV should be delivered quickly after being bitten by rabid animals, even if these symptoms are not present. Human rabies vaccination can be given to people with the following forms of rabies: Patients with livid rabies exhibit hyperactivity, hydrophobia, and aerophobia, and die after a few days owing to cardiopulmonary collapse. The course of paralytic rabies is longer than that of livid rabies. The muscle at the location of the wound becomes paralysed. Then, gradually, unconsciousness sets in, eventually leading to death. This kind is frequently misdiagnosed. It accounts for 30 percent of all human cases.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Human Rabies Vaccines Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Human Rabies Vaccines Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Human Rabies Vaccines Market: • Serum Institute of India • Sanofi Pasteur,Inc • Novartis Vaccines and Diagnostics,Ltd • Cadila Pharmaceuticals Ltd • Merck and Co.Inc • Glaxosmithkline Biologicals • Berna Biotech Ltd • Wyeth pharmaceuticals • Medimmune LLC • Cipla,Inc (Note: The list of the major players will be updated with the latest market scenario and trends)
Human Rabies Vaccines Market Segmentation: By Product Type • Vero Cell Rabies Vaccine • Baby Hamster Kidney (BHK) • Chick Embryo Cell Rabies Vaccine • Others
By Application • Pre-Exposure Prophylaxis • Post-Exposure Prophylaxis
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Human Rabies Vaccines Market Sample Video:
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Human Rabies Vaccines Market By Product Type, By Application and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Human Rabies Vaccines Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Human Rabies Vaccines Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Human Rabies Vaccines Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Human Rabies Vaccines Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Vero Cell Rabies Vaccine 7.2. Baby Hamster Kidney (BHK) 7.3. Chick Embryo Cell Rabies Vaccine 7.4. Others 8. Human Rabies Vaccines Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Pre-Exposure Prophylaxis 8.2. Post-Exposure Prophylaxis 9. North America Human Rabies Vaccines Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028 10. Latin America Human Rabies Vaccines Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028 11. Europe Human Rabies Vaccines Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028 12. Asia Pacific Human Rabies Vaccines Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028 14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. Serum Institute of India 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Sanofi Pasteur,Inc 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Novartis Vaccines and Diagnostics,Ltd 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Cadila Pharmaceuticals Ltd 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Merck and Co.Inc 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Glaxosmithkline Biologicals 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Berna Biotech Ltd 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Wyeth pharmaceuticals 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Medimmune LLC 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10.Cipla,Inc 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11.Ferring Pharmaceuticals 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12.Cipla Ltd 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics